Company intelligence / Profile preview

Guizhou Xinbang Pharmaceutical

Ownership: Private
Employees: ~5059
Development stage: Other

Overview

Guizhou Xinbang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and sale of Chinese herbal medicines and other pharmaceutical products. The company has a diversified business model with significant revenue from pharmaceutical distribution and medical services. It is investing in new drug pipelines targeting chronic diseases such as diabetes and cardiovascular conditions. Financial performance has faced challenges but shows signs of gradual recovery.

Therapeutic areas: GastroenterologyEndocrinologyCardiovascular
Modalities: Small moleculeBiologicChinese herbal medicine
Industry: Biotech

Beyond the preview

Go deeper on Guizhou Xinbang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guizhou Xinbang Pharmaceutical.

Explore the full profile